肿瘤标志物

肿瘤标志物r－GTⅡ，GST－π在肝细胞癌组织内的表达及其意义

Expression and its Significance of Tumor Marker r-GT ⅱ, GST - π in Hepatocellular Carcinoma

目的评估一种新的肿瘤标志物&肿瘤M2型丙酮酸激酶（TumorM2-PK）对于胃肠道恶性肿瘤的诊断价值。

Objective To evaluate the diagnostic value of a new tumor marker Tumor M2 PK in gastrointestinal cancer .

循环DNA杂合性缺失作为肿瘤标志物在肺癌诊断上的应用

Analysis of Circulating Tumour DNA in Plasma to Diagnosis Lung Cancer

蛋白芯片检测系统（多肿瘤标志物C（12）系统）的应用评价

Evaluate the clinical value of protein chip system ( c_ ( 12 )) for detecting multi-marker of tumor

将纳米技术与DNA适体技术相结合，对电极表面进行修饰，制备成探针，应用于肿瘤标志物抗原的识别。

Probes fabricated based on electrode surfaces , modified by nano-technologies and aptamers , were used for antigen identification .

DNA甲基化状态改变作为肿瘤标志物用于临床诊断，其特点和操作优于突变的检测。

The characteristic and procedure of DNA methylation changes as tumor markers for the clinical diagnosis is superior to mutation detection .

目的探讨肺孤立性病变CT表现与血清3种常用肿瘤标志物检测联合诊断的价值。

Objective To evaluate the combinative diagnostic value of CT representation and estimation of several common serum tumor markers of pulmonary solitary lesion .

肿瘤标志物cyClinD1与肿瘤预后相关性

The Relationship of the tumor mark cyclin D_1 with the tumor prognosis

用生物发光免疫技术检测肝肿瘤标志物AFP在肝癌早期诊断中的研究

The Detection of Liver Tumor Marked AFP by Bioluminescence Technology in Early Liver Carcinoma Diagnose

Tg（甲状腺球蛋白）是非常重要的随访分化型甲状腺癌的血清肿瘤标志物。

Tg ( thyroglobulin ) is an established serum tumour marker in the follow-up of differentiated thyroid cancer .

目的探讨p53蛋白作为肿瘤标志物在肺癌诊断中的意义。

Objective To explore the usefulness of p53 immunohistochemical staining as a marker of malignancy in the diagnosis of lung cancer .

目的：进一步研究血浆Kras基因突变和肿瘤标志物诊断胰腺癌的价值。

Objective : To further study the clinical value of plasma K-ras mutation and serum tumor markers in diagnosis of pancreatic carcinoma .

结论：肿瘤标志物AFP、AFU、GGT、5′-NT对PHC有一定的诊断价值，4种肿瘤标志物联合检测可提高诊断PHC的敏感性。

Conclusions : These four tumor marker have some diagnostic value for PHC .

本文就表面增强激光解吸电离（Surfaceenhancedlaserdesorption/ionization，SELDI）蛋白质芯片的原理及近年来在肿瘤标志物筛选中的应用做一简要综述。

This article introduces the theory of surface enhanced laser desorption / ionization ( SELDI ) protein chip and its application in selecting of tumor markers .

以SSX基因mRNA作为肿瘤标志物检测循环中的肝癌细胞

Detection of circulating hepatocellular carcinoma cells with SSX gene mRNA as tumor marker

且部分峰值变化与肿瘤标志物甲胎蛋白、HBVDNA载量、临床肝功能指标存在相关性。

The changes of peak values of several peaks were correlated with tumor markers such as alpha-fetoprotein ( AFP ), HBV DNA copies , albumin and prothrombin time .

四种肿瘤标志物水平在NHL分期中的意义。

To study the serum level of the 4 tumor markers related to the clinical stages .

同时用SPSS100统计软件及接受器工作性能曲线（ROC）分析，评价肿瘤标志物的临床应用价值。

All data were analyzed by SPSS 10 0 and Receiver Operating Characteristic Curve ( ROC ) .

血浆K-ras突变和肿瘤标志物诊断胰腺癌的临床价值

Clinical value of plasma K-ras mutation and serum tumor markers in diagnosis of pancreatic carcinoma

结论18F-FDG显像联合血肿瘤标志物检测能明显提高结直肠癌复发的检出率。

Conclusion18F-FDG imaging and CEA , CA242 can discover the recurrent of colorectal cancer .

癌胚抗原（carcinoembryonicantigen，CEA）是结直肠癌诊疗过程中应用最为广泛的肿瘤标志物。

Carcinoembryonic antigen ( CEA ) is one of the most widely used tumor marker to diagnose and monitor recurrence for Colorectal carcinoma .

目的：探讨CT扫描和血清肿瘤标志物（NSE、Cyfra211）检测联合应用对小细胞肺癌（SCLC）的临床诊断价值。

Objective To investigate the clinic diagnosis value of CT scan combined with the determination of serum NSE , Cyfra 21-1 for SCLC .

上皮细胞膜抗原（Epithelialmembraneantigen，EMA）虽不属肿瘤标志物范畴，但与肿瘤标志物有许多相近之处，如组织的相对特异性。

Although Epithelial Membrane Antigen ( EMA ) is not a tumor marker , there is great similarity to it , for example , the relative organ specificity .

结论：NSE作为肿瘤标志物在恶性肿瘤的诊断具有重要的临床意义。

Conclusion As a tumor marker , NSE has important clinical significance in the diagnoses of malignant tumor and pneumonia .

而基线KPS评分，肿瘤标志物对疗效均无明显影响。

And baseline KPS score , tumor markers had no significant impact on the efficacy .

BCL-2蛋白的表达能否作为膀胱肿肿瘤标志物志物及与膀胱肿瘤患者存活有否关系仍需进一步深入的研究。

Whether BCL-2 protein expression can be considered as a bladder tumor marker and if it was correlated with the patient survival , it should be further studied .

目的分析和探讨肿瘤标志物CEA、SCC、NSE在非小细胞肺癌临床预诊中的价值。

Objective Analyse and discuss the value of CEA 、 SCC 、 NSE in clinical diagnosis of non-small cell carcinoma of lung .

NMP22肿瘤标志物诊断尿路上皮癌的初步评价

Evaluation of NMP22 in Detection of Urinary Tract Transitional Cell Carcinoma

SELDI-TOF-MS技术在检测乳腺癌肿瘤标志物中的应用

Application of SELDI-TOF-MS to tumor marker detection in galactophore cancer

结论CA19-9本身并不完全是肿瘤标志物。

Conclusion CA19-9 self is not an absolute tumor marker .